BRUKER CORPORATION Cash and Cash Equivalents, Period Increase (Decrease)
BRUKER CORPORATION (BRKR) reported Cash and Cash Equivalents, Period Increase (Decrease) of $75.30 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-01.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2017-03-01
- BRUKER CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2016-12-31 was $63.70M.
- BRUKER CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2016-09-30 was $46.20M, a 352.94% increase year-over-year.
- BRUKER CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2016-06-30 was $22.60M.
- BRUKER CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2016-03-31 was -$57.20M, a 481.33% decline year-over-year.
- BRUKER CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2016 was $75.30M.
- BRUKER CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$52.40M.
- BRUKER CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2014 was -$119.20M, a 193.05% decline from fiscal 2013.
- BRUKER CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2013 was $128.10M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2016-12-31 | $63.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $109.90M derived: sum of 2 quarters · filed 2017-03-01 | $132.50M derived: sum of 3 quarters · filed 2017-03-01 | $75.30M 10-K · filed 2017-03-01 |
| 2016-09-30 | $46.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $68.80M derived: sum of 2 quarters · filed 2016-11-09 | $11.60M 10-Q · filed 2016-11-09 | -$52.30M derived: sum of 4 quarters · filed 2017-03-01 |
| 2016-06-30 | $22.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$34.60M 10-Q · filed 2016-08-05 | -$98.50M derived: sum of 3 quarters · filed 2017-03-01 | -$88.30M derived: sum of 4 quarters · filed 2017-03-01 |
| 2016-03-31 | -$57.20M 10-Q · filed 2016-05-06 | -$121.10M derived: sum of 2 quarters · filed 2017-03-01 | -$110.90M derived: sum of 3 quarters · filed 2017-03-01 | -$124.60M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-12-31 | -$63.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$53.70M derived: sum of 2 quarters · filed 2017-03-01 | -$67.40M derived: sum of 3 quarters · filed 2017-03-01 | -$52.40M 10-K · filed 2017-03-01 |
| 2015-09-30 | $10.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$3.50M derived: sum of 2 quarters · filed 2016-11-09 | $11.50M 10-Q · filed 2016-11-09 | $1.80M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$13.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $1.30M 10-Q · filed 2016-08-05 | -$8.40M derived: sum of 3 quarters · filed 2017-03-01 | -$69.00M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $15.00M 10-Q · filed 2016-05-06 | $5.30M derived: sum of 2 quarters · filed 2017-03-01 | -$55.30M derived: sum of 3 quarters · filed 2017-03-01 | |
| 2014-12-31 | -$9.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$70.30M derived: sum of 2 quarters · filed 2017-03-01 | -$119.20M 10-K · filed 2017-03-01 | |
| 2014-09-30 | -$60.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$109.50M 10-Q · filed 2015-11-06 | ||
| 2014-06-30 | -$48.90M 10-Q · filed 2015-08-07 | |||
| 2013-12-31 | $128.10M 10-K · filed 2016-02-29 | |||
| 2011-12-31 | $15.60M 10-K · filed 2012-02-29 | |||
| 2011-06-30 | -$23.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | -$60.60M 10-Q · filed 2011-08-09 | ||
| 2011-03-31 | -$37.10M 10-Q · filed 2011-05-09 | |||
| 2010-12-31 | $23.30M 10-K · filed 2012-02-29 | |||
| 2010-06-30 | -$15.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | -$19.50M 10-Q · filed 2011-08-09 | ||
| 2010-03-31 | -$4.00M 10-Q · filed 2011-05-09 | |||
| 2009-12-31 | $40.90M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |